ALSFRS‐R

@article{Gordon2004ALSFRSR,
  title={ALSFRS‐R},
  author={P. Gordon and R. Miller and D. Moore},
  journal={Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders},
  year={2004},
  volume={5},
  pages={90 - 93}
}
  • P. Gordon, R. Miller, D. Moore
  • Published 2004
  • Medicine
  • Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
  • The ALSFRS‐R is an attractive primary outcome measure in clinical trials of ALS because it is validated, easy to administer, minimizes dropout, reduces cost, and correlates with survival. Unlike the other standard outcome measures currently employed, the ALSFRS‐R is also a measure of global function. 
    19 Citations
    R(+) pramipexole as a mitochondrially focused neuroprotectant: Initial early phase studies in ALS
    • 34
    Quantitative objective markers for upper and lower motor neuron dysfunction in ALS
    • 173
    • PDF

    References

    SHOWING 1-10 OF 15 REFERENCES
    The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function
    • 1,911
    • Highly Influential
    • PDF
    Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials
    • 232
    • Highly Influential
    Unified Huntington's disease rating scale: A follow up
    • 109
    Phase II/II/III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis
    • Neurology
    • 2001
    ACTS) Group
    • A double-blind, placebo controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology
    • 1996
    A controlled trial of recombinant-methionyl BDNF (r-metHuBDNF) in ALS
    • Neurology
    • 1999
    ACTS) Group. A double-blind, placebo controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis
    • Neurology
    • 1996
    ACTS) Phase I-II Study Group. The Amyotrophic Lateral Sclerosis Functional Rating Scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis
    • Arch Neurol
    • 1996